AsoGen Therapeutics IVS: Financial statements 2020
CVR: 40357092
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
AsoGen Therapeutics IVS (CVR 40357092) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -7,007 and a net result of DKK -39,300. Equity in the 2020 report amounted to DKK -55,744.
- Gross Profit
- DKK -7,007
- Profit/Loss
- DKK -39,300
- Equity
- DKK -55,744
- Total Assets
- DKK 238,392
Official annual report
How creditworthy is AsoGen Therapeutics IVS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
AsoGen Therapeutics IVS has published its interim report for the period March 15, 2019 to December 31, 2019.
About AsoGen Therapeutics IVS
AsoGen Therapeutics IVS was a Danish company of the type Iværksætterselskab based in Odense S, founded in 2019. The company has been dissolved on 8 June 2022. The company was registered under the industry Fremstilling af farmaceutiske præparater. In 2020, the company reported a gross profit of DKK -7,007 and a net result of DKK -39,300. Equity in the 2020 report amounted to DKK -55,744.